Pages that link to "Q43295115"
Jump to navigation
Jump to search
The following pages link to Thiazolidinediones and fractures in men and women (Q43295115):
Displaying 50 items.
- Initial Combination Therapy for Type 2 Diabetes Mellitus: Is It Ready for Prime Time? (Q30397995) (← links)
- Risk of fracture with thiazolidinediones: an individual patient data meta-analysis. (Q30611122) (← links)
- Safety and tolerability of sitagliptin in clinical studies: a pooled analysis of data from 10,246 patients with type 2 diabetes (Q33562235) (← links)
- Therapeutic Implications of PPARgamma in Human Osteosarcoma (Q33674615) (← links)
- Vildagliptin has the same safety profile as a sulfonylurea on bone metabolism and bone mineral density in post-menopausal women with type 2 diabetes: a randomized controlled trial (Q33691585) (← links)
- Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data (Q33694542) (← links)
- Thiazolidinedione use and the longitudinal risk of fractures in patients with type 2 diabetes mellitus (Q33736122) (← links)
- Insulin use and Excess Fracture Risk in Patients with Type 2 Diabetes: A Propensity-Matched cohort analysis. (Q33812674) (← links)
- Bone loss in diabetes: use of antidiabetic thiazolidinediones and secondary osteoporosis (Q34161200) (← links)
- Thiazolidinediones and fractures: evidence from translating research into action for diabetes (Q34630672) (← links)
- PPARγ: a circadian transcription factor in adipogenesis and osteogenesis (Q35093192) (← links)
- Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs. (Q36297873) (← links)
- Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations (Q36333089) (← links)
- Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study (Q36486802) (← links)
- Is thiazolidinediones use a factor in delaying the need for insulin therapy in type 2 patients with diabetes? A population-based cohort study (Q36496431) (← links)
- Management of type-2 diabetes mellitus in adults: focus on individualizing non-insulin therapies (Q36523427) (← links)
- Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database (Q36563665) (← links)
- Safety of Anti-Diabetic Therapies on Bone (Q36716222) (← links)
- Intensive glycemic control and thiazolidinedione use: effects on cortical and trabecular bone at the radius and tibia (Q36807306) (← links)
- Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment (Q36942108) (← links)
- Obesity is not protective against fracture in postmenopausal women: GLOW (Q36980595) (← links)
- Impact of conjugated linoleic acid on bone physiology: proposed mechanism involving inhibition of adipogenesis (Q37270218) (← links)
- Drug treatment of type 2 diabetes mellitus in patients for whom metformin is contraindicated (Q37509313) (← links)
- Insulin sensitizers in nonalcoholic fatty liver disease and steatohepatitis: Current status (Q37634350) (← links)
- Update on the safety of thiazolidinediones (Q37738725) (← links)
- Inverse association of PPARγ agonists use and high grade glioma development (Q37742514) (← links)
- Thiazolidinediones in the treatment of patients with Post-Transplant-Hyperglycemia or new-onset diabetes mellitus after renal transplantation (NODAT) - A new therapeutic option? (Q37760855) (← links)
- Thiazolinedione treatment in PCOS--an update (Q37763184) (← links)
- Fixed-dose combination therapy for type 2 diabetes: sitagliptin plus pioglitazone (Q37772523) (← links)
- Weight Management in Type 2 Diabetes Mellitus (Q37801634) (← links)
- The safety of thiazolidinediones (Q37848841) (← links)
- Thiazolidinediones and fracture risk in patients with Type 2 diabetes (Q37889370) (← links)
- New understanding and treatments for osteoporosis (Q37969683) (← links)
- Do thiazolidinediones still have a role in treatment of type 2 diabetes mellitus? (Q38092275) (← links)
- Sulfonylureas and risk of falls and fractures: a systematic review (Q38101007) (← links)
- Oral anti-diabetic drugs and fracture risk, cut to the bone: safe or dangerous? A narrative review (Q38441017) (← links)
- Dapagliflozin combination therapy in type 2 diabetes mellitus (Q38634051) (← links)
- Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future (Q38641190) (← links)
- Diabetes Drug Effects on the Skeleton. (Q38999214) (← links)
- Patterns of Prescription Drug Use Before and After Fragility Fracture (Q39466222) (← links)
- Review article: effects of type 2 diabetes therapies on bone metabolism (Q42363966) (← links)
- Type 2 diabetes: uses of thiazolidinediones and insulin (Q42576525) (← links)
- Elevated vitamin D status in postmenopausal women on thiazolidinediones for type 2 diabetes (Q44448589) (← links)
- Androgens and estrogens prevent rosiglitazone-induced adipogenesis in human mesenchymal stem cells (Q44899614) (← links)
- Cardiovascular, ocular and bone adverse reactions associated with thiazolidinediones: a disproportionality analysis of the US FDA adverse event reporting system database (Q46643138) (← links)
- Efficacy and safety of gemigliptin, a dipeptidyl peptidase-4 inhibitor, in patients with type 2 diabetes mellitus inadequately controlled with combination treatment of metformin and sulphonylurea: a 24-week, multicentre, randomized, double-blind, pl (Q51233383) (← links)
- Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes. (Q51298932) (← links)
- A 26‐week, placebo‐ and pioglitazone‐controlled monotherapy study of rivoglitazone in subjects with type 2 diabetes mellitus (Q51355720) (← links)
- Pioglitazone Therapy and Fractures: Systematic Review and Meta-Analysis. (Q52570655) (← links)
- Management Strategies for Posttransplant Diabetes Mellitus after Heart Transplantation: A Review. (Q52603541) (← links)